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Background
Since the introduction of biologic agents, expectations of
medical treatment for chronic arthritides have increased
markedly. It is now agreed upon that estimation of effec-
tiveness of these drugs requires not only the assessment of
relative improvement in signs and symptoms, but the
evaluation of their ability to induce a state of CR or, at
least, MDA. In recent years, several criteria for assessing
CR and MDA in adult rheumatoid arthritis (RA) or JIA
have been developed.
Objective
To apply existing definitions of CR or MDA in a large sam-
ple of visits made in JIA patients.
Methods
851 visits made in 446 patients between 1992 and 2006
were assessed. CR was defined as achieving: 1) DAS28
score <2.4; 2) SDAI score ≤ 3.3; 3) CDAI score ≤ 2.8; 4)
Clinical remission criteria for RA; 5) preliminary defini-
tion of CR for JIA. LDA was defined as achieving: 1)
DAS28 score <3.6; 2) SDAI score ≤ 11; 3) CDAI score ≤ 10;
3) LDA criteria for RA; 4) LDA criteria for JIA.
Results
Table 1: shows the percentage of patients classified in state
of CR or MDA by each criterion.
Conclusion
Definition of CR in JIA proved more restrictive than corre-
spondent definitions for adult RA. The proportion of
patients classified in MDA by JIA criteria and DAS28,
CDAI and SDAI criteria was similar, whereas RA criteria
for LDA led to classify relatively more patients in such
state.
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Table 1: The percentage of patients classified in state of CR or 
MDA by each criterion
DAS28 SDAI CDAI RA criteria JIA criteria
CR 19.3 19.2 18.7 13.0 10.8
MDA 25.7 23.4 22.7 38.3 21.9
